RF
+
Structure of a camel nanobody illustration Nanobodies are also known as single domain antibodies They are small in size with novel therapeutic cha
RF
+
Structure of a camel nanobody illustration Nanobodies are also known as single domain antibodies They are small in size with novel therapeutic cha
RF
+
Structure of a camel nanobody illustration Nanobodies are also known as single domain antibodies They are small in size with novel therapeutic cha
RF
+
Nanobodies and Covid-19 virus spike protein illustration
RM
+
Nanobody aSA3 complexed with SARS-CoV-1 RBD molecular model Shown are the dimeric spike glycoproteins (yellow blue) of the receptor binding protein
RM
+
Nanobody aSA3 complexed with SARS-CoV-1 RBD molecular model Shown are the dimeric spike glycoproteins (yellow blue) of the receptor binding protein
RM
+
Illustration of a nanobody bound to the synthetic antiparallel homodimer (APH) coiled-coil peptide Nanobodies are fragments of an antibody consisting
RM
+
Human parathyroid hormone receptor-1 dimer molecular model The image shows the parathyroid hormone (red) which is being recognized by a hormone-rela
RM
+
Human parathyroid hormone receptor-1 dimer illustration
RM
+
G-proteins complexed with PTHrP and PTH1R illustration
RM
+
G-proteins complexed with PTHrP and PTH1R illustration
RM
+
SARS-CoV-2 receptor binding domain complexed with nanobody Nb70 molecular model The image shows the spike protein S1 of the receptor binding domain
RM
+
SARS-CoV-2 receptor binding domain complex illustration
RM
+
Vobarilizumab molecular model
RM
+
Vobarilizumab nanobody molecular model The image shows the two chains of Vobarilizumab (green purple) sulphate ions (red yellow) and part of a gl
RM
+
Llama VHH antibody D7 complexed with HIV-1 gp120 core molecular model The image shows the llama antibody (nanobody) D7 (blue) targeting the CD4-bind
RM
+
Llama VHH antibody D7 complexed with HIV-1 gp120 core molecular model The image shows the llama antibody (nanobody) D7 (blue) targeting the CD4-bind
RM
+
Superoxide dismutase 1 (SOD1) complexed with nanobody 2 (Nb2) molecular model The image shows the superoxide dismutase (blue) the nanobody (magenta
RM
+
Superoxide dismutase 1 (SOD1) complexed with nanobody 2 (Nb2) molecular model The image shows the superoxide dismutase (blue) the nanobody (magenta
RM
+
Poliovirus capsid complexed with nanobody VHH PVSP19B from Camelus dromedarius The image shows the poliovirus capsid consisting of the capsid protein
RM
+
Poliovirus capsid complexed with nanobody VHH PVSP19B from Camelus dromedarius The image shows the poliovirus capsid consisting of the capsid protein
RM
+
Ricin complexed with antibody V5G6 molecular model
RM
+
Ricin complexed with antibody V5G6 molecular model The image shows two ricin chains (green pink) the anti-RON nanobody (blue) and three glucopyran
RM
+
Glutamate transporter nanobody therapy illustration
RM
+
Nanobody and antibody size comparison Illustration of the relative sizes of a nanobody (left) and an antibody (right) Both are capable of recognizin
RM
+
Molecular model of SARS-CoV-2 spike complexed with a neutralizing synthetic nanobody mNb6 The image shows the trimeric spike structure (blue red ye
RM
+
SARS-CoV-2 spike complexed with nanobody molecular model
RF
+
Molecular model of nanobodies (blue) binding to the receptor binding domain (RBD) of the SARS-CoV-2 coronavirus spike (S) protein (red) S proteins ar
RF
+
Molecular model of nanobodies (blue) binding to the receptor binding domain (RBD) of the SARS-CoV-2 coronavirus spike (S) protein (red) S proteins ar
RM
+
Molecular model of nanobodies (yellow) binding to the receptor binding domain (RBD pink) of the SARS-CoV-2 coronavirus spike (S) protein (blue) S pr
RM
+
Molecular model of nanobodies (yellow) binding to the receptor binding domain (RBD pink) of the SARS-CoV-2 coronavirus spike (S) proteins (blue) S p
RM
+
Molecular model of nanobodies (yellow) binding to the receptor binding domain (RBD pink) of the SARS-CoV-2 coronavirus spike (S) protein (blue) S pr
RM
+
Molecular model of nanobodies (yellow) binding to the receptor binding domain (RBD pink) of the SARS-CoV-2 coronavirus spike (S) protein (blue) S pr
RM
+
Molecular model of nanobodies (yellow) binding to the receptor binding domain (RBD pink) of the SARS-CoV-2 coronavirus spike (S) protein (blue) S pr
34
0
https://www.afloimages.com/search/nanobody.html